Centene Corporation (CNC)
NYSE: CNC · IEX Real-Time Price · USD
77.57
-0.49 (-0.63%)
May 20, 2024, 4:00 PM EDT - Market closed

Centene Revenue

Centene had revenue of $155.52B in the twelve months ending March 31, 2024, with 6.34% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $40.41B with 3.90% year-over-year growth. In the year 2023, Centene had annual revenue of $154.00B with 6.54% growth.

Revenue (ttm)
$155.52B
Revenue Growth
+6.34%
P/S Ratio
0.27
Revenue / Employee
$2,321,149
Employees
67,000
Market Cap
41.40B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023154.00B9.45B6.54%
Dec 31, 2022144.55B18.57B14.74%
Dec 31, 2021125.98B14.87B13.38%
Dec 31, 2020111.12B36.48B48.87%
Dec 31, 201974.64B14.52B24.16%
Dec 31, 201860.12B11.73B24.25%
Dec 31, 201748.38B7.78B19.15%
Dec 31, 201640.61B17.85B78.41%
Dec 31, 201522.76B6.20B37.44%
Dec 31, 201416.56B5.70B52.44%
Dec 31, 201310.86B2.75B33.95%
Dec 31, 20128.11B2.90B55.62%
Dec 31, 20115.21B763.15M17.16%
Dec 31, 20104.45B345.46M8.42%
Dec 31, 20094.10B738.35M21.95%
Dec 31, 20083.36B595.49M21.51%
Dec 31, 20072.77B946.58M51.94%
Dec 31, 20061.82B590.24M47.90%
Dec 31, 20051.23B231.26M23.10%
Dec 31, 20041.00B231.21M30.04%
Dec 31, 2003769.73M308.24M66.79%
Dec 31, 2002461.49M134.92M41.31%
Dec 31, 2001326.57M105.22M47.54%
Dec 31, 2000221.35M19.92M9.89%
Dec 31, 1999201.43M50.99M33.90%
Dec 31, 1998150.44M--
Dec 31, 1997---
Dec 31, 1996---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cencora 276.54B
Humana 109.24B
Takeda Pharmaceutical 28.16B
GE HealthCare Technologies 19.50B
IQVIA Holdings 15.07B
Haleon 14.31B
Biogen 9.66B
Alcon 9.56B
Revenue Rankings